Zhangzhou Pientzehuang Pharmaceutical Co Ltd banner

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 139.32 CNY 0.05%
Market Cap: ¥84.1B

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Common Shares Outstanding

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Common Shares Outstanding
¥603.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Common Shares Outstanding
¥6.1B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Common Shares Outstanding
¥6.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Common Shares Outstanding
¥1.8B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
6%
Zhejiang Nhu Co Ltd
SZSE:002001
Common Shares Outstanding
¥3B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
5%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Common Shares Outstanding
¥401m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Glance View

Market Cap
84.1B CNY
Industry
Pharmaceuticals

Zhangzhou Pientzehuang Pharmaceutical Co. Ltd., nestled in the heart of Fujian Province, China, is a firm steeped in history and tradition, yet thriving in today’s modern pharmaceutical landscape. The company is best known for its signature product, Pientzehuang Pills, a centuries-old traditional Chinese medicine believed to offer hepatoprotective and detoxifying properties. Rooted in ancient formulations, Pientzehuang Pills are celebrated for their efficacy in addressing liver ailments and enhancing overall vitality. This has secured their place as a staple in Chinese households, maintaining cultural resonance while appealing to a broader audience through the global rise in demand for alternative medicine. The firm operates with a delicate balance, integrating traditional Chinese medicine practices with increasingly sophisticated production technologies to ensure quality consistency and scalability. Zhangzhou Pientzehuang leverages its brand heritage and expertise in traditional herbal remedies to drive revenue. The company has adeptly positioned itself within both domestic and international markets, capitalizing on the growing interest in holistic health approaches. By focusing on research and development, the company continues to innovate, expanding its product line to include health supplements and preventive solutions that cater to modern health challenges. Its strategic distribution channels, including hospitals, pharmacies, and online platforms, enable broad market penetration, ensuring robust sales growth. This dual strategy of preserving the traditional while embracing the modern allows the company to keep its legacy relevant in a competitive pharmaceutical industry, thereby securing its stronghold in the market and ensuring sustained financial performance.

Intrinsic Value
87.85 CNY
Overvaluation 37%
Intrinsic Value
Price ¥139.32

See Also

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
603.3m CNY

Based on the financial report for Sep 30, 2025, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Common Shares Outstanding amounts to 603.3m CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
0%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett